Concepedia

Michael Vredenburg

MV

Statistics

Publications

6

Citations

219

H-Index

6

Active since

2001

Affiliations

Seattle Cancer Care Alliance(Current)

University of Washington

Massachusetts General Hospital

University of Pennsylvania

Roswell Park Comprehensive Cancer Center

Michael Vredenburg is an author at Seattle Cancer Care Alliance specializing in health sciences, medicine, and immunodeficiencies.

ORCID

Top concepts

Publications per year

2001–2023

6

Publications

6

Effects of Orally Active Taxanes on P-Glycoprotein Modulation and Colon and Breast Carcinoma Drug Resistance

Michael Vredenburg, Iwao Ojima, Jean Veith et al. · JNCI Journal of the National Cancer Institute · 2001 · 80 citations · Full text

Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study

Hanny Al‐Samkari, Debbie Jiang, Terry Gernsheimer et al. · British Journal of Haematology · 2022 · 70 citations · Full text

, , +22

Cost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures

Christine Barnett, Deirdre Mladsi, Michael Vredenburg et al. · Journal of Medical Economics · 2018 · 31 citations

The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells

Tracy A. Brooks, Kieran L. O’Loughlin, Hans Minderman et al. · Investigational New Drugs · 2006 · 15 citations

, , +6

Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia

Shivi Jain, Terry Gernsheimer, Scott Kolodny et al. · Platelets · 2023 · 12 citations · Full text

1–5 of 6